Production (Stage)
CannaPharmaRX, Inc.
CPMD
$0.004
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -30.45% | 54.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -30.45% | 54.42% | |||
| Cost of Revenue | -61.82% | 228.42% | |||
| Gross Profit | 70.65% | -380.80% | |||
| SG&A Expenses | 205.63% | -210.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -49.91% | 147.15% | |||
| Operating Income | 56.08% | -205.30% | |||
| Income Before Tax | 81.54% | -2,085.56% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 81.54% | -2,085.56% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 81.54% | -2,085.56% | |||
| EBIT | 56.08% | -205.30% | |||
| EBITDA | 55.13% | -243.12% | |||
| EPS Basic | 82.14% | -1,966.67% | |||
| Normalized Basic EPS | 80.00% | -1,850.00% | |||
| EPS Diluted | 82.14% | -1,966.67% | |||
| Normalized Diluted EPS | 80.00% | -1,850.00% | |||
| Average Basic Shares Outstanding | -0.04% | 0.04% | |||
| Average Diluted Shares Outstanding | -0.04% | 0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||